Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-000376

EVP & Chief Financial Officer sold 32,000 shares at $20.00 ($640,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MCGRATH JOHN EVP & Chief Financial Officer 2017-12-29 Sale −32,000 $20.00 $640,000 96,654 D: show line 1 in the form
Open-market sales · 32,000 sh · avg $20.00 · $640,000
Loading xslF345X03/doc4.xml…